CRE rat for Psychiatric Disorders

用于治疗精神疾病的 CRE 大鼠

基本信息

  • 批准号:
    8132657
  • 负责人:
  • 金额:
    $ 19.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2013-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): It is estimated that addiction and its associated costs: crime, domestic violence and child abuse, health care costs, and loss of employment and family structure, exceed half of a trillion dollars per year. Fighting addiction is not a matter of willpower, it is a battle to understand how drugs affect the brain and can permanently alter its function. One of the key limitations to understanding the cellular and genetic basis of a complex disease like addiction is the availability of good models to test hypotheses related to cells and genes and their functions. The laboratory rat is one model which has tremendous value because of its intensely studied physiological, biochemical, and behavioral characteristics and their genome sequence similarities to humans. More than 2000 genetic determinants of disease-related traits have been initially described in the rat, however, it has been difficult to precisely correlate specific genes with these traits because of limitations in technology for manipulating the rat genome. In the past 4 years, we have been developing new tools to close this technology gap. We have developed new and efficient ways of making transgenic rats using transposable elements which are highly reproducible and we were the first to apply zinc-finger nuclease (ZFN) technology to target and disrupt, or knock out, specific genes in the rat. These are two very important technologies that allow us to do many things, but more work is needed. Many times, knocking out a gene in the whole animal precludes studying its role in a particular cell or tissue because the gene is essential for early embryo development and so knocking it out causes the animal to die. In other cases, knocking out the gene in the whole animal doesn't allow one to distinguish what organ (or part of the brain, for example) the gene is functioning in to cause the disease. In this pilot/feasibility study, we propose to develop the next key technological step toward this goal - to be able to specifically disrupt genes in a particular cell or tissue at a particular time. We will develop transgenic rats which express an inducible CRE/loxP recombinase system in specific tissues. This system will allow us to create conditional knockout rats where we can control where and when a gene function is removed from a cell. We will focus brain neuron systems known to be important for studying addiction and behavior - the dopaminergic and serotonergic neurons. As a proof of principal that the system is working, we will knock out the gene that produces serotonin, a hormone that is important in the reward system of the brain and an integral player in addiction and other psychiatric disorders, specifically in neurons of the hindbrain. If successful, this approach will change the way we can approach genes, cells and diseases in the laboratory rat model to impact the socioeconomic burdens of addiction and drug abuse. PUBLIC HEALTH RELEVANCE: The key to developing effective therapies for the treatment of addiction and other psychiatric disorders is the identification of genes and the cells they work in to target new drugs and approaches. Lab rats are the preferred model for studying addiction by many resources, but the technology to study a particular gene by knocking out its function in a particular cell or tissue has not been demonstrated. This pilot and feasibility study aims to develop that technology in the lab rat so we can enable studies of specific genes and their roles in addictive behavior and other diseases.
描述(由申请人提供):据估计,成瘾及其相关成本:犯罪、家庭暴力和虐待儿童、医疗保健成本以及失业和家庭结构的损失,每年超过一万亿美元。与成瘾作斗争不是意志力的问题,而是一场了解药物如何影响大脑并永久改变其功能的战斗。了解成瘾等复杂疾病的细胞和遗传基础的关键限制之一是是否有良好的模型来测试与细胞和基因及其功能相关的假设。实验室大鼠是一种具有巨大价值的模型,因为其生理、生化和行为特征及其与人类基因组序列的相似性得到了深入研究。最初在大鼠中描述了 2000 多个疾病相关性状的遗传决定因素,然而,由于操纵大鼠基因组的技术的限制,很难将特定基因与这些性状精确关联。在过去 4 年中,我们一直在开发新工具来缩小这一技术差距。我们开发了利用高度可重复的转座元件制造转基因大鼠的新的、有效的方法,并且我们是第一个应用锌指核酸酶(ZFN)技术来靶向和破坏或敲除大鼠中的特定基因的人。这是两项非常重要的技术,使我们能够做很多事情,但还需要做更多的工作。很多时候,敲除整个动物中的一个基因就无法研究它在特定细胞或组织中的作用,因为该基因对于早期胚胎发育至关重要,因此敲除它会导致动物死亡。在其他情况下,敲除整个动物中的基因不允许人们区分该基因在哪个器官(或大脑的一部分)中起作用以导致疾病。在这项试点/可行性研究中,我们建议开发实现这一目标的下一个关键技术步骤——能够在特定时间特异性破坏特定细胞或组织中的基因。我们将培育在特定组织中表达诱导型 CRE/loxP 重组酶系统的转基因大鼠。该系统将使我们能够创造条件性基因敲除大鼠,我们可以控制基因功能从细胞中去除的位置和时间。我们将重点关注已知对研究成瘾和行为很重要的大脑神经元系统——多巴胺能和血清素能神经元。作为该系统正常工作的原理证明,我们将敲除产生血清素的基因,血清素是一种在大脑奖励系统中非常重要的激素,也是成瘾和其他精神疾病(特别是后脑神经元)中不可或缺的参与者。 。如果成功,这种方法将改变我们在实验室大鼠模型中处理基因、细胞和疾病的方式,从而影响成瘾和药物滥用的社会经济负担。 公共健康相关性:开发治疗成瘾和其他精神疾病的有效疗法的关键是识别基因及其作用的细胞以靶向新药物和方法。实验室老鼠是许多资源研究成瘾的首选模型,但通过敲除特定细胞或组织中特定基因的功能来研究特定基因的技术尚未得到证实。这项试点和可行性研究旨在在实验室老鼠身上开发这项技术,以便我们能够研究特定基因及其在成瘾行为和其他疾病中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Aron M Geurts其他文献

Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease.
通过核酸酶 Zygote 电穿孔进行高效 CRISPR/Cas9 介导的小鼠基因组编辑。
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Wenning Qin;Stephanie L Dion;Peter M Kutny;Yingfan Zhang;Albert W Cheng;Nathaniel L Jillette;Ankit Malhotra;Aron M Geurts;Yi-Guang Chen;Haoyi Wang
  • 通讯作者:
    Haoyi Wang
A revamped rat reference genome improves the discovery of genetic diversity in laboratory rats
改造后的大鼠参考基因组促进了实验室大鼠遗传多样性的发现
  • DOI:
    10.1016/j.xgen.2024.100527
  • 发表时间:
    2024-03-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tristan V de Jong;Yanchao Pan;P. Rastas;D. Munro;M. Tutaj;Huda Akil;Chris Benner;Denghui Chen;Apurva S. Chitre;W. Chow;V. Colonna;Clifton L. Dalgard;Wendy M Demos;P. A. Doris;Erik Garrison;Aron M Geurts;Hakan M Gunturkun;Victor Guryev;Thibaut Hourlier;K. Howe;Jun Huang;Ted Kalbfleisch;Panjun Kim;Ling Li;Spencer Mahaffey;Fergal J. Martin;P. Mohammadi;A. B. Ozel;O. Polesskaya;M. Pravenec;Pjotr Prins;J. Sebat;Jennifer R. Smith;Leah C. Solberg Woods;B. Tabakoff;A. Tracey;Marcela Uliano;F. Villani;Hongyang Wang;Burt M Sharp;F. Telese;Zhihua Jiang;Laura Saba;Xusheng Wang;Terence D Murphy;Abraham A. Palmer;A. Kwitek;M. Dwinell;Robert W. Williams;Jun Z. Li;Hao Chen
  • 通讯作者:
    Hao Chen

Aron M Geurts的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Aron M Geurts', 18)}}的其他基金

Role of chromatin conformation in BP Regulation
染色质构象在血压调节中的作用
  • 批准号:
    10667385
  • 财政年份:
    2020
  • 资助金额:
    $ 19.13万
  • 项目类别:
Role of chromatin conformation in BP Regulation
染色质构象在血压调节中的作用
  • 批准号:
    10023347
  • 财政年份:
    2020
  • 资助金额:
    $ 19.13万
  • 项目类别:
Role of chromatin conformation in BP Regulation
染色质构象在血压调节中的作用
  • 批准号:
    10238141
  • 财政年份:
    2020
  • 资助金额:
    $ 19.13万
  • 项目类别:
Role of chromatin conformation in BP Regulation
染色质构象在血压调节中的作用
  • 批准号:
    10460347
  • 财政年份:
    2020
  • 资助金额:
    $ 19.13万
  • 项目类别:
Role of chromatin conformation in BP Regulation
染色质构象在血压调节中的作用
  • 批准号:
    10667385
  • 财政年份:
    2020
  • 资助金额:
    $ 19.13万
  • 项目类别:
CRE rat for Psychiatric Disorders
用于治疗精神疾病的 CRE 大鼠
  • 批准号:
    8249029
  • 财政年份:
    2011
  • 资助金额:
    $ 19.13万
  • 项目类别:
Advanced genetic engineering technology development
先进基因工程技术开发
  • 批准号:
    8145528
  • 财政年份:
    2011
  • 资助金额:
    $ 19.13万
  • 项目类别:
GENETIC MODEL TRACKING AND MONITORING CORE
遗传模型跟踪和监测核心
  • 批准号:
    8592332
  • 财政年份:
  • 资助金额:
    $ 19.13万
  • 项目类别:
GENETIC MODEL TRACKING AND MONITORING CORE
遗传模型跟踪和监测核心
  • 批准号:
    9091609
  • 财政年份:
  • 资助金额:
    $ 19.13万
  • 项目类别:
GENETIC MODEL TRACKING AND MONITORING CORE
遗传模型跟踪和监测核心
  • 批准号:
    8726478
  • 财政年份:
  • 资助金额:
    $ 19.13万
  • 项目类别:

相似国自然基金

眶额叶-前岛叶环路在成瘾强迫性觅药行为中的作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
海马-伏隔核连接改变介导网络成瘾影响青少年自伤行为发生风险的作用机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
父代METH暴露对子代成瘾易感行为的影响及其mPFC中ADRB1机制研究
  • 批准号:
    82211540400
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
数字成瘾影响幼儿执行功能的行为与脑机制研究
  • 批准号:
    62277037
  • 批准年份:
    2022
  • 资助金额:
    56 万元
  • 项目类别:
    面上项目
腹侧被盖区多巴胺能神经元O-GlcNAc糖基化稳态调控成瘾强化行为的作用及机制研究
  • 批准号:
    32271064
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目

相似海外基金

Deciphering biased agonistic activation of mu-opioid receptor by novel optogenetic hydrogen peroxide sensor
新型光遗传学过氧化氢传感器破译μ阿片受体的偏向激动激活
  • 批准号:
    10604662
  • 财政年份:
    2023
  • 资助金额:
    $ 19.13万
  • 项目类别:
New Technologies for Accelerating the Discovery and Characterization of Neuroactives that Address Substance Use Disorders
加速发现和表征解决药物使用障碍的神经活性物质的新技术
  • 批准号:
    10680754
  • 财政年份:
    2023
  • 资助金额:
    $ 19.13万
  • 项目类别:
Gene Regulation in the Opioid Dependent Human Brain (Project 2)
阿片类药物依赖性人脑的基因调控(项目 2)
  • 批准号:
    10493706
  • 财政年份:
    2022
  • 资助金额:
    $ 19.13万
  • 项目类别:
Orexin modulation of brain reward-brain stress system interactions in alcohol withdrawal anxiety
食欲素调节酒精戒断焦虑中大脑奖赏-大脑应激系统相互作用
  • 批准号:
    10569020
  • 财政年份:
    2022
  • 资助金额:
    $ 19.13万
  • 项目类别:
Orexin modulation of brain reward-brain stress system interactions in alcohol withdrawal anxiety
食欲素调节酒精戒断焦虑中大脑奖赏-大脑应激系统相互作用
  • 批准号:
    10302090
  • 财政年份:
    2022
  • 资助金额:
    $ 19.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了